Halozyme Therapeutics, Inc. (HALO) Shorts Could Be Feeling the Heat

Halozyme Therapeutics, Inc. (HALO) short sellers may have hedged with long calls

Jan 7, 2015 at 1:31 PM
facebook twitter linkedin


With Halozyme Therapeutics, Inc.'s (NASDAQ:HALO) annual analyst and investor day currently underway, the stock has rallied more than 8% to trade at $10.92. Today's positive price action is likely being met with mixed reactions from traders in and out of the options pits.

In the options arena, speculators at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) have bought to open 52.46 calls for every put over the past 10 sessions. What's more, this ratio ranks in the 94th percentile of its annual range, meaning calls have been bought to open over puts with more rapidity just 6% of the time within the past year.

Elsewhere on the Street, however, short interest accounts for 25.4% of the stock's available float, and it would take more than four weeks to cover these bets, at average daily trading volumes. It's possible, then, that some of the recent call-buying -- particularly at out-of-the-money strikes -- is a result of short sellers hedging their bearish bets.

Regardless of the reason, now is not an opportune time to purchase short-term options on Halozyme Therapeutics, Inc.'s (NASDAQ:HALO). Specifically, the equity's Schaeffer's Volatility Index (SVI) of 1.20 sits higher than all other comparable readings taken in the past year, suggesting the stock's front-month options are expensive, from a volatility perspective.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

SCHAEFFER'S JULY STOCKS REPORT AD
 


 


 
Special Offers from Schaeffer's Trading Partners